Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
48
ASH Quote, Financials, Valuation and Earnings
Last price:
$54.39
Seasonality move
:
2.12%
Day range:
$52.44 - $54.46
52-week range:
$45.21 - $102.50
Dividend yield:
2.98%
P/E ratio:
21.24x
P/S ratio:
1.30x
P/B ratio:
0.99x
Volume:
910.8K
Avg. volume:
756.7K
1-year change:
-42.95%
Market cap:
$2.6B
Revenue:
$2.1B
EPS (TTM):
-$0.66
Analysts' Opinion
-
Consensus RatingAshland has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $72.67, Ashland has an estimated upside of 33.6% from its current price of $54.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $58.00 representing -6.64% downside risk from its current price of $54.39.
Fair Value
-
According to the consensus of 10 analysts, Ashland has 33.6% upside to fair value with a price target of $72.67 per share.
ASH vs. S&P 500
-
Over the past 5 trading days, Ashland has overperformed the S&P 500 by 4.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ashland does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ashland revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ashland reported revenues of $405M.
Earnings Growth
-
Ashland earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ashland reported earnings per share of -$3.50.
Enterprise value:
3.7B
EV / Invested capital:
--
Price / LTM sales:
1.30x
EV / EBIT:
209.59x
EV / Revenue:
1.79x
PEG ratio (5yr expected):
7.83x
EV / Free cash flow:
61.00x
Price / Operating cash flow:
44.42x
Enterprise value / EBITDA:
60.00x
Gross Profit (TTM):
$632M
Return On Assets:
-0.4%
Net Income Margin (TTM):
-1.12%
Return On Equity:
-0.79%
Return On Invested Capital:
-0.54%
Operating Margin:
0.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.4B | $2.1B | $2B | $473M | $405M | |
| Gross Profit | $835M | $601M | $632M | $98M | $111M | |
| Operating Income | $282M | $107M | $101M | -$18M | $3M | |
| EBITDA | $519M | $434M | $61M | $94M | -$140M | |
| Diluted EPS | $16.11 | $3.04 | -$0.66 | $0.51 | -$3.50 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.7B | $1.7B | $1.4B | $1.1B | |
| Total Assets | $6.7B | $6.5B | $6.3B | $5.9B | $5.2B | |
| Current Liabilities | $585M | $908M | $464M | $414M | $425M | |
| Total Liabilities | $3.6B | $3.8B | $2.9B | $2.8B | $2.6B | |
| Total Equity | $3.1B | $2.8B | $3.3B | $3.1B | $2.6B | |
| Total Debt | $1.7B | $2B | $1.3B | $1.3B | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$282M | $493M | $184M | $187M | -$40M | |
| Cash From Investing | $1.5B | -$108M | -$43M | -$26M | -$18M | |
| Cash From Financing | -$912M | -$483M | -$362M | -$139M | -$22M | |
| Free Cash Flow | -$403M | $310M | $60M | $151M | -$63M | |
ASH
Sector
Market Cap
$2.6B
$18.2M
Price % of 52-Week High
53.06%
62.16%
Dividend Yield
2.98%
0%
Shareholder Yield
10.64%
1.27%
1-Year Price Total Return
-42.95%
-15.57%
Beta (5-Year)
0.578
0.918
Dividend yield:
2.98%
Annualized payout:
$1.58
Payout ratio:
-334.78%
Growth streak:
6 years
Technicals
8-day SMA
Buy
Level
$52.66
200-day SMA
Sell
Level
$75.01
Bollinger Bands (100)
Sell
Level
54.92 - 71.98
Chaikin Money Flow
Buy
Level
185.4M
20-day SMA
Buy
Level
$51.43
Relative Strength Index (RSI14)
Buy
Level
53.16
ADX Line
Sell
Level
25.21
Williams %R
Sell
Level
-0.8737
50-day SMA
Sell
Level
$56.35
MACD (12, 26)
Sell
Level
-0.83
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
192.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2464)
Buy
CA Score
(Annual)
Level (-0.2312)
Buy
Beneish M-Score
(Annual)
Level (-2.9361)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.4411)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Stock Forecast FAQ
In the current month, ASH has received 7 Buy ratings 3 Hold ratings, and 0 Sell ratings. The ASH average analyst price target in the past 3 months is $72.67.
-
Where Will Ashland Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ashland share price will rise to $72.67 per share over the next 12 months.
-
What Do Analysts Say About Ashland?
Analysts are divided on their view about Ashland share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ashland is a Sell and believe this share price will drop from its current level to $58.00.
-
What Is Ashland's Price Target?
The price target for Ashland over the next 1-year time period is forecast to be $72.67 according to 10 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is ASH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ashland is a Buy. 7 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ASH?
You can purchase shares of Ashland via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ashland shares.
-
What Is The Ashland Share Price Today?
Ashland was last trading at $54.39 per share. This represents the most recent stock quote for Ashland. Yesterday, Ashland closed at $54.39 per share.
-
How To Buy Ashland Stock Online?
In order to purchase Ashland stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
20
EVVTY alert for May 1
Evolution AB [EVVTY] is down 19.01% over the past day.
Sell
47
LANC alert for May 1
Lancaster Colony [LANC] is down 15.56% over the past day.
Sell
36
BHE alert for May 1
Benchmark Electronics [BHE] is down 15.02% over the past day.
